Company / R&D per Share
Atea Pharmaceuticals, Inc. R&D per Share History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.99
FY2022
5-year range
$0.12 / $0.99
FY2020-FY2022
Trend
+699.2%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share changed +699% YoY in FY2022, a notable deviation from the 2-year average annual change of +309%.
Based on SEC 10-K filings.
0.99 in FY2022.
Improved from $0.66 to $0.99 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, r&d per share increased 699.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 10.30 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.99 | +699.2% |
| FY2021 | $0.12 | -81.3% |
| FY2020 | $0.66 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026